99 related articles for article (PubMed ID: 30565691)
1. Clusterin enhances AKT2-mediated motility of normal and cancer prostate cells through a PTEN and PHLPP1 circuit.
Bertacchini J; Mediani L; Beretti F; Guida M; Ghalali A; Brugnoli F; Bertagnolo V; Petricoin E; Poti F; Arioli J; Anselmi L; Bari A; McCubrey J; Martelli AM; Cocco L; Capitani S; Marmiroli S
J Cell Physiol; 2019 Jul; 234(7):11188-11199. PubMed ID: 30565691
[TBL] [Abstract][Full Text] [Related]
2. Heat shock protein 47 promotes tumor survival and therapy resistance by modulating AKT signaling
Chern Y; Zhang P; Ju H; Tai IT
Cancer Biol Med; 2020 May; 17(2):343-356. PubMed ID: 32587773
[No Abstract] [Full Text] [Related]
3. Mislocalization of the E3 ligase, β-transducin repeat-containing protein 1 (β-TrCP1), in glioblastoma uncouples negative feedback between the pleckstrin homology domain leucine-rich repeat protein phosphatase 1 (PHLPP1) and Akt.
Warfel NA; Niederst M; Stevens MW; Brennan PM; Frame MC; Newton AC
J Biol Chem; 2011 Jun; 286(22):19777-88. PubMed ID: 21454620
[TBL] [Abstract][Full Text] [Related]
4. PTEN-regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate cancer progression.
Miller KA; Degan S; Wang Y; Cohen J; Ku SY; Goodrich DW; Gelman IH
Oncogene; 2024 Jan; 43(1):22-34. PubMed ID: 37875657
[TBL] [Abstract][Full Text] [Related]
5. Crosstalk of the EphA2 receptor with a serine/threonine phosphatase suppresses the Akt-mTORC1 pathway in cancer cells.
Yang NY; Fernandez C; Richter M; Xiao Z; Valencia F; Tice DA; Pasquale EB
Cell Signal; 2011 Jan; 23(1):201-12. PubMed ID: 20837138
[TBL] [Abstract][Full Text] [Related]
6. PLEKHS1 drives PI3Ks and remodels pathway homeostasis in PTEN-null prostate.
Chessa TAM; Jung P; Anwar A; Suire S; Anderson KE; Barneda D; Kielkowska A; Sadiq BA; Lai IW; Felisbino S; Turnham DJ; Pearson HB; Phillips WA; Sasaki J; Sasaki T; Oxley D; Spensberger D; Segonds-Pichon A; Wilson M; Walker S; Okkenhaug H; Cosulich S; Hawkins PT; Stephens LR
Mol Cell; 2023 Aug; 83(16):2991-3009.e13. PubMed ID: 37567175
[TBL] [Abstract][Full Text] [Related]
7. Crosstalk between PKCα and PI3K/AKT Signaling Is Tumor Suppressive in the Endometrium.
Hsu AH; Lum MA; Shim KS; Frederick PJ; Morrison CD; Chen B; Lele SM; Sheinin YM; Daikoku T; Dey SK; Leone G; Black AR; Black JD
Cell Rep; 2018 Jul; 24(3):655-669. PubMed ID: 30021163
[TBL] [Abstract][Full Text] [Related]
8. Sprouty2, PTEN, and PP2A interact to regulate prostate cancer progression.
Patel R; Gao M; Ahmad I; Fleming J; Singh LB; Rai TS; McKie AB; Seywright M; Barnetson RJ; Edwards J; Sansom OJ; Leung HY
J Clin Invest; 2013 Mar; 123(3):1157-75. PubMed ID: 23434594
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol biogenesis is a PTEN-dependent actionable node for the treatment of endocrine therapy-refractory cancers.
Kaysudu I; Gungul TB; Atici S; Yilmaz S; Bayram E; Guven G; Cizmecioglu NT; Sahin O; Yesiloz G; Haznedaroglu BZ; Cizmecioglu O
Cancer Sci; 2023 Nov; 114(11):4365-4375. PubMed ID: 37706278
[TBL] [Abstract][Full Text] [Related]
10. CLU (clusterin) promotes mitophagic degradation of MSX2 through an AKT-DNM1L/Drp1 axis to maintain SOX2-mediated stemness in oral cancer stem cells.
Praharaj PP; Patra S; Mishra SR; Mukhopadhyay S; Klionsky DJ; Patil S; Bhutia SK
Autophagy; 2023 Aug; 19(8):2196-2216. PubMed ID: 36779631
[TBL] [Abstract][Full Text] [Related]
11. Increased carbonylation of the lipid phosphatase PTEN contributes to Akt2 activation in a murine model of early alcohol-induced steatosis.
Shearn CT; Smathers RL; Backos DS; Reigan P; Orlicky DJ; Petersen DR
Free Radic Biol Med; 2013 Dec; 65():680-692. PubMed ID: 23872024
[TBL] [Abstract][Full Text] [Related]
12. Progression of prostate cancer by synergy of AKT with genotropic and nongenotropic actions of the androgen receptor.
Xin L; Teitell MA; Lawson DA; Kwon A; Mellinghoff IK; Witte ON
Proc Natl Acad Sci U S A; 2006 May; 103(20):7789-94. PubMed ID: 16682621
[TBL] [Abstract][Full Text] [Related]
13. NAP1L5 facilitates pancreatic ductal adenocarcinoma progression via TRIM29-mediated ubiquitination of PHLPP1.
Xiao B; Ge Y; Zhao R; Zhang Y; Guo Y; Zhang S; Li B; Qiu P; Chao Z; Zuo S
Biochem Pharmacol; 2023 Nov; 217():115811. PubMed ID: 37717692
[TBL] [Abstract][Full Text] [Related]
14. PTEN is both an activator and a substrate of chaperone-mediated autophagy.
Zhang KK; Burns CM; Skinner ME; Lombard DB; Miller RA; Endicott SJ
J Cell Biol; 2023 Sep; 222(9):. PubMed ID: 37418003
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of PHLPP1/2 phosphatases rescues pancreatic β-cells in diabetes.
Lupse B; Annamalai K; Ibrahim H; Kaur S; Geravandi S; Sarma B; Pal A; Awal S; Joshi A; Rafizadeh S; Madduri MK; Khazaei M; Liu H; Yuan T; He W; Gorrepati KDD; Azizi Z; Qi Q; Ye K; Oberholzer J; Maedler K; Ardestani A
Cell Rep; 2021 Aug; 36(5):109490. PubMed ID: 34348155
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of HNF1B/Clusterin axis enhances disease progression in a highly aggressive subset of pancreatic cancer patients.
Yang S; Tang W; Azizian A; Gaedcke J; Ströbel P; Wang L; Cawley H; Ohara Y; Valenzuela P; Zhang L; Lal T; Sinha S; Rupin E; Hanna N; Ghadimi BM; Hussain SP
Carcinogenesis; 2022 Dec; 43(12):1198-1210. PubMed ID: 36426859
[TBL] [Abstract][Full Text] [Related]
17. Crosstalk between PTEN/Akt2 and TGFbeta signaling involving EGF receptor down-regulation during the tumor promotion process from the early stage in a rat two-stage hepatocarcinogenesis model.
Taniai E; Kawai M; Dewa Y; Nishimura J; Harada T; Saegusa Y; Matsumoto S; Takahashi M; Mitsumori K; Shibutani M
Cancer Sci; 2009 May; 100(5):813-20. PubMed ID: 19309364
[TBL] [Abstract][Full Text] [Related]
18. Hyperphosphorylated PTEN exerts oncogenic properties.
van Ree JH; Jeganathan KB; Fierro Velasco RO; Zhang C; Can I; Hamada M; Li H; Baker DJ; van Deursen JM
Nat Commun; 2023 May; 14(1):2983. PubMed ID: 37225693
[TBL] [Abstract][Full Text] [Related]
19. Sodium selenite increases the activity of the tumor suppressor protein, PTEN, in DU-145 prostate cancer cells.
Berggren M; Sittadjody S; Song Z; Samira JL; Burd R; Meuillet EJ
Nutr Cancer; 2009; 61(3):322-31. PubMed ID: 19373605
[TBL] [Abstract][Full Text] [Related]
20. The role and function of CLU in cancer biology and therapy.
Zhang Y; Lv X; Chen L; Liu Y
Clin Exp Med; 2023 Sep; 23(5):1375-1391. PubMed ID: 36098834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
